Galmed Pharmaceuticals (GLMD) Other Working Capital Changes (2016 - 2018)

Galmed Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$270000.0 for Q2 2018.

• In Q2 2018, Other Working Capital Changes changed 0.0% year-over-year to -$270000.0; the TTM figure through Dec 2018 stood at -$538000.0 (up 50.41% YoY), while the FY2018 annual figure was -$538000.0, up 50.41% from the prior year.
• Other Working Capital Changes was -$270000.0 for Q2 2018 at Galmed Pharmaceuticals, down from -$268000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.9 million in Q3 2016 to a low of -$274000.0 in Q4 2016.
• Historically, Other Working Capital Changes has averaged $0.0 across 3 years, with a median of -$270000.0 in 2017.
• Biggest YoY gain for Other Working Capital Changes was 0.36% in 2017; the steepest drop was 114.44% in 2017.
• A 3-year view of Other Working Capital Changes shows it stood at -$274000.0 in 2016, then increased by 0.36% to -$273000.0 in 2017, then rose by 1.1% to -$270000.0 in 2018.
• The last three Other Working Capital Changes figures came in at -$270000.0 (Q2 2018), -$268000.0 (Q1 2018), and -$273000.0 (Q4 2017), per Business Quant data.